Center for Scientific Review; Notice of Closed Meeting, 12892-12894 [05-5166]
Download as PDF
<![CDATA[
12892
Federal Register / Vol. 70, No. 50 / Wednesday, March 16, 2005 / Notices
is hereby given of a meeting of the
Board of Scientific Counselors, National
Library of Medicine.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting. The meeting
will be closed to the public as indicated
below in accordance with the provisions
set forth in section 552b(c)(6). Title 5
U.S.C., as amended for the review,
discussion, and evaluation of individual
intramural programs and projects
conducted by the National Library of
Medicine, including consideration of
personnel qualifications and
performance, and the competence of
individual investigators, the disclosure
of which would constitute a clearly
unwarranted invasion of personal
privacy.
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
into the building by non-government
employees. Persons without a government
I.D. will need to show a photo I.D. and sign
in at the security desk upon entering the
building.
Name of Committee: Board of Scientific
Counselors, National Library of Medicine,
Board of Scientific Counselors, Lister Hill
Center.
Date: May 12–13, 2005.
Open: May 12, 2005, 9 a.m. to 1 p.m.
Agenda: Review of research and
development programs and preparation of
reports of the Lister Hill Center for
Biomedical Communications.
Place: National Library of Medicine,
Building 38, 2nd Floor, Board Room, 8600
Rockville Pike, Bethesda, MD 20892.
Closed: May 12, 2005, 1 p.m. to 2 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Library of Medicine,
Building 38, 2nd Floor, Board Room, 8600
Rockville Pike, Bethesda, MD 20892.
Open: May 12, 2005, 2 p.m. to 5 p.m.
Agenda: Review of research and
development programs and preparation of
reports of the Lister Hill Center for
Biomedical Communications.
Place: National Library of Medicine,
Building 38, 2nd Floor, Board Room, 8600
Rockville Pike, Bethesda, MD 20892.
Open: May 13, 2005, 9 a.m. to 12 p.m.
Agenda: Review of research and
development programs and preparation of
reports of the Lister Hill Center for
Biomedical Communications.
Place: National Library of Medicine,
Building 38, 2nd Floor, Board Room, 8600
Rockville Pike, Bethesda, MD 20892.
Contact Person: Jackie Duley, Program
Assistant, Lister Hill National Center for
Biomedical Communications, National
Library of Medicine, Building 38A, Room
7N–707, Bethesda, MD 20892, (301) 496–
4441.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
Center for Scientific Review; Amended
Notice of Meeting
VerDate jul<14>2003
16:45 Mar 15, 2005
Jkt 205001
(Catalogue of Federal Domestic Assistance
Program Nos. 93.789, Medical Library
Assistance, National Institutes of Health,
HHS)
Dated: March 10, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–5161 Filed 3–15–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Notice is hereby given of a change in
the meeting of the Center for Scientific
Review Special Emphasis Panel, March
14, 2005, 8 p.m. to March 15, 2005, 5
p.m., Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD, 20814 which
was published in the Federal Register
on February 22, 2005, 70 FR 8597–8599.
The starting time of the meeting on
March 14, 2005 has been changed to 8
a.m. until adjournment. The meeting
dates and location remain the same. The
meeting is closed to the public.
Dated: March 10, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–5164 Filed 3–15–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. appendix 2), notice
is hereby given of a meeting of the
National Institutes of Health Peer
Review Advisory Committee.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: National Institutes of
Health Peer Review Advisory Committee.
Date: May 16, 2005.
Time: 8:30 a.m. to 5 p.m.
Agenda: Provide technical and scientific
advice to the Director, National Institutes of
Health (NIH), the Deputy Director for
Extramural Research, NIH and the Director,
Center for Scientific Review (CSR), on
matters relating broadly to review procedures
and policies for the evaluation of scientific
and technical merit of applications for grants
and awards.
Place: Bethesda Marriott, 5151 Pooks Hill
Road, Bethesda, MD 20814.
Contact Person: Karl Malik, PhD, Executive
Secretary, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, room 3110, MSC 7776, Bethesda, MD
20892, (301) 594–6806, malikk@csr.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 98.893, National
Institutes of Health, HHS)
Dated: March 10, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–5165 Filed 3–15–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
E:\FR\FM\16MRN1.SGM
16MRN1
Federal Register / Vol. 70, No. 50 / Wednesday, March 16, 2005 / Notices
Name of Committee: Center for Scientific
Review Special Emphasis Panel,
Hematopoietic Stem Cells.
Date: March 18, 2005.
Time: 2 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Delia Tang, MD, Scientific
Review Administrator, Center for Scientific
Review, National Institutes of Health, 6701
Rockledge Drive, Room 4126, MSC 7802,
Bethesda, MD 20892, 301–435–2506,
tangd@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, ZRG1 NCF
(09).
Date: March 22, 2005.
Time: 12 p.m. to 3 p.m.
Agenda: To review and evaluate grant
application.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Lawrence Baizer, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4152,
MSC 7850, Bethesda, MD 20892, (301) 435–
1257, baizer@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Member
Conflict-Motivated Behaviors.
Date: March 24, 2005.
Time: 12:15 p.m. to 1:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Christine L. Melchior,
PhD, Scientific Review Administrator, Center
for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5176,
MSC 7844, Bethesda, MD 20892, 301–435–
1713, melchioc@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, SensoryMotor Integration.
Date: March 25, 2005
Time: 12 p.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Daniel R. Kenshalo, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5176,
MSC 7844, Bethesda, MD 20892, 301–435–
1255, kenshalod@csr.nih.gov.
VerDate jul<14>2003
16:45 Mar 15, 2005
Jkt 205001
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Genetic
Bases of Psychiatric Disorders
Date: March 28, 2005.
Time: 11 a.m. to 1 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: David J. Remondini, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2210,
MSC 7890, Bethesda, MD 20892, 301/435–
1038, remondid@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Gene
Expression in Vascular Myocytes.
Date: March 28, 2005.
Time: 1 p.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Ai-Ping Zou, PhD, MD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4118,
MSC 7814, Bethesda, MD 20892, 301–435–
1777, zouai@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Radiation
Biology.
Date: March 28, 2005.
Time: 12 p.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Syed M. Quadri, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6210,
MSC 7804, Bethesda, MD 20892, (301) 435–
1211, quadris@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel,
Neurodegeneration, Neurogenesis, and
Regeneration.
Date: March 31, 2005.
Time: 2 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
12893
Contact Person: Lawrence Baizer, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4152,
MSC 7850, Bethesda, MD 20892, (301) 435–
1257, baizerl@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, DentalSmall Business Applications Special
Emphasis Panel.
Date: April 1, 2005.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Betehsda Marriott Suites, 6711
Democracy Boulebard, Betehsda, MD 20817.
Contact Person: Donald F. McDonald, PhD,
Chief, Renal and Urological Scineces IRG,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Room 4214, MSC 7814, Bethesda, MD 20892,
(301) 435–1215, mcdonald@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel,
Chemoprevention of Cancer.
Date: April 4, 2005.
Time: 1:30 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Eun Ah Cho, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6202,
MSC 7804, Bethesda, MD 20892, (301) 435–
4467, choe@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Molecular
Dissection of E. Histolytica Pathogenesis.
Date: April 4, 2005.
Time: 3 a.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Joseph D. Mosca, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5158,
MSC 7808, Bethesda, MD 20892, (301) 435–
2344, moscajos@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Hematology
Bioengineering.
Date: April 8, 2005.
Time: 10:30 a.m. to 12 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Watergate, 2650 Virginia
Avenue, NW., Washington, DC 20037.
Contact Person: Delia Tang, MD, Scientific
Review Administrator, Center for Scientific
Review, National Institutes of Health, 6701
Rockledge Drive, Room 4126, MSC 7802,
Bethesda, MD 20892, 301–435–2506,
tangd@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research; 93.306, 93.333,
93.337, 903.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
E:\FR\FM\16MRN1.SGM
16MRN1
12894
Federal Register / Vol. 70, No. 50 / Wednesday, March 16, 2005 / Notices
Dated: March 10, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–5166 Filed 3–15–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Proposed Collection;
Comment Request
In compliance with section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 concerning
opportunity for public comment on
proposed collections of information, the
Substance Abuse and Mental Health
Services Administration will publish
periodic summaries of proposed
projects. To request more information
on the proposed projects or to obtain a
copy of the information collection
plans, call the SAMHSA Reports
Clearance Officer on (240) 276–1243.
These programs will be implemented by
9–10 CSAP-funded grantees and their
partnering worksites. The primary
purpose of the evaluation will be to
study the effectiveness of modified
model and effective drug-free workplace
prevention and early intervention
programs and interventions for
incoming populations of young
employees. This will provide the
Nation’s public and private employers
with empirical information about
effective strategies to utilize for these
incoming employees in preventing and
intervening early with substance abuse.
A web-based survey will be used to
collect data from employees at the
participating grantee worksites at
baseline and at 1- and 2-year follow-up
points. The survey is composed of OMB
approved CSAP’s Government
Performance and Results Act (GPRA)
outcome measures such as prevalence of
drug and alcohol use, perceptions of
risk, and attitudes and beliefs and a set
of supplementary questions capturing
workplace outcomes such as
productivity, absenteeism and
accidents.
Comments are invited on: (a) Whether
the proposed collections of information
are necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
Proposed Project: The Workplace
Prevention and Early Intervention
Transitioning Youth Into the
Workplace (YIW) Cross-Site
Evaluation—New
The Substance Abuse and Mental
Health Services Administration’s
(SAMHSA), Center for Substance Abuse
Prevention (CSAP) plans to conduct a
cross-site evaluation of the effectiveness
of workplace-based substance abuse
prevention and early intervention
programs for young adults (ages 16–24).
TOTAL BURDEN HOURS FOR THE CROSS-SITE WEB-BASED SURVEY
Number of
responses
per
respondent
Number of
respondents
Instrument/Activity
Average burden
hours per
respondent
Total burden
hours
Baseline Data Collection ...............................................................................
1-year Follow-up Data Collection (80% of baseline) ....................................
2-year Follow-up Data Collection (80% of 1-year follow-up) .......................
6,500
5,200
4,160
1
1
1
35 mins .............
35 mins .............
35 mins .............
3,792
3,033
2,427
Total .......................................................................................................
15,860
........................
...........................
9,252
Annualized Burden (over 3 years) ................................................................
5,287
........................
...........................
3,084
Send comments to Summer King,
SAMHSA Reports Clearance Officer,
Room 71–1045, One Choke Cherry
Road, Rockville, MD 20857. Written
comments should be received within 60
days of this notice.
Dated: March 9, 2005.
Patricia S. Bransford,
Acting Executive Officer, SAMHSA.
[FR Doc. 05–5142 Filed 3–15–05; 8:45 am]
BILLING CODE 4162–20–P
DEPARTMENT OF HOMELAND
SECURITY
Coast Guard
[CGD08–05–013]
Implementation of Sector Mobile
AGENCY:
Coast Guard, DHS.
VerDate jul<14>2003
16:45 Mar 15, 2005
Jkt 205001
ACTION:
Notice of organizational change.
SUMMARY: The Coast Guard announces
the stand-up of Sector Mobile. Sector
Mobile Commanding Officer has the
authority, responsibility and missions of
Group Mobile and Marine Safety Office
Mobile in one command. The Coast
Guard has established a continuity of
operations whereby all previous
practices and procedures will remain in
effect until superseded by an authorized
Coast Guard official or document.
DATES: This notice is effective March 25,
2005.
ADDRESSES: Documents indicated in this
preamble as being available in the
docket are part of docket CGD08–05–
013 and are available for inspection or
copying at Commander (rpl), Eighth
Coast Guard District, 500 Poydras Street,
New Orleans, Louisiana 70130–3310
between 7:30 a.m. and 4:30 p.m.,
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
Monday through Friday, except Federal
holidays.
FOR FURTHER INFORMATION CONTACT:
Lieutenant Michael Roschel, Eighth
District Planning Office at 504–589–
6293.
SUPPLEMENTARY INFORMATION:
Discussion of Notice
Sector Mobile is located at Building
102, Brookley Complex, Mobile, AL
36615–1390 and contains a single
Command Center. Sector Mobile is
composed of a Response Department,
Prevention Department, and Logistics
Department. All existing missions and
functions performed by Group Mobile
and Marine Safety Office Mobile have
been operating under this new
organizational structure since
September 15, 2004. Effective March 25,
2005, Group Mobile and Marine Safety
E:\FR\FM\16MRN1.SGM
16MRN1
]]>Agencies
[Federal Register Volume 70, Number 50 (Wednesday, March 16, 2005)]
[Notices]
[Pages 12892-12894]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-5166]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
[[Page 12893]]
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Hematopoietic Stem Cells.
Date: March 18, 2005.
Time: 2 p.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Delia Tang, MD, Scientific Review Administrator,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 4126, MSC 7802, Bethesda, MD 20892, 301-435-
2506, tangd@csr.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, ZRG1 NCF (09).
Date: March 22, 2005.
Time: 12 p.m. to 3 p.m.
Agenda: To review and evaluate grant application.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Lawrence Baizer, PhD, Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4152, MSC 7850, Bethesda, MD
20892, (301) 435-1257, baizer@csr.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Member Conflict-Motivated Behaviors.
Date: March 24, 2005.
Time: 12:15 p.m. to 1:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Christine L. Melchior, PhD, Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5176, MSC 7844, Bethesda, MD
20892, 301-435-1713, melchioc@csr.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Sensory-Motor Integration.
Date: March 25, 2005
Time: 12 p.m. to 2 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Daniel R. Kenshalo, PhD, Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5176, MSC 7844, Bethesda, MD
20892, 301-435-1255, kenshalod@csr.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Genetic Bases of Psychiatric Disorders
Date: March 28, 2005.
Time: 11 a.m. to 1 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: David J. Remondini, PhD, Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2210, MSC 7890, Bethesda, MD
20892, 301/435-1038, remondid@csr.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Gene Expression in Vascular Myocytes.
Date: March 28, 2005.
Time: 1 p.m. to 2 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Ai-Ping Zou, PhD, MD, Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4118, MSC 7814, Bethesda, MD
20892, 301-435-1777, zouai@csr.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Radiation Biology.
Date: March 28, 2005.
Time: 12 p.m. to 2 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Syed M. Quadri, PhD, Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6210, MSC 7804, Bethesda, MD
20892, (301) 435-1211, quadris@csr.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Neurodegeneration, Neurogenesis, and Regeneration.
Date: March 31, 2005.
Time: 2 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Lawrence Baizer, PhD, Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4152, MSC 7850, Bethesda, MD
20892, (301) 435-1257, baizerl@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Dental-Small Business Applications Special Emphasis Panel.
Date: April 1, 2005.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Betehsda Marriott Suites, 6711 Democracy Boulebard,
Betehsda, MD 20817.
Contact Person: Donald F. McDonald, PhD, Chief, Renal and
Urological Scineces IRG, Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive, Room 4214, MSC 7814,
Bethesda, MD 20892, (301) 435-1215, mcdonald@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Chemoprevention of Cancer.
Date: April 4, 2005.
Time: 1:30 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Eun Ah Cho, PhD, Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6202, MSC 7804, Bethesda, MD
20892, (301) 435-4467, choe@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Molecular Dissection of E. Histolytica Pathogenesis.
Date: April 4, 2005.
Time: 3 a.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Joseph D. Mosca, PhD, Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5158, MSC 7808, Bethesda, MD
20892, (301) 435-2344, moscajos@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Hematology Bioengineering.
Date: April 8, 2005.
Time: 10:30 a.m. to 12 p.m.
Agenda: To review and evaluate grant applications.
Place: The Watergate, 2650 Virginia Avenue, NW., Washington, DC
20037.
Contact Person: Delia Tang, MD, Scientific Review Administrator,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 4126, MSC 7802, Bethesda, MD 20892, 301-435-
2506, tangd@csr.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research; 93.306, 93.333,
93.337, 903.393-93.396, 93.837-93.844, 93.846-93.878, 93.892,
93.893, National Institutes of Health, HHS)
[[Page 12894]]
Dated: March 10, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-5166 Filed 3-15-05; 8:45 am]
BILLING CODE 4140-01-M
